Real-World Treatment Outcomes of an Artificial Tear Containing Arabinogalactan, Hyaluronic Acid and Trehalose Among Subjects with Dry Eye
This real-life post-marketing study demonstrated clinical improvement of signs and symptoms in patients with dry eye disease using a new artificial tear medical device based on arabinogalactan, hyaluronic acid, and trehalose.
Authors
- Stefano Remiddi (ORCID: https://orcid.org/0009-0004-7795-6016)
- Giulia Grazia (ORCID: https://orcid.org/0000-0003-2411-3555)
- Luís Oliveira (ORCID: https://orcid.org/0000-0001-7532-5991)
- Andrea Bedei
- Pedro Rocha Cabrera
- Laura Castellini
Institutions
- Ministry of Defence (IT)
- Hospital de Santo António (PT)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/opth.s480668
- Citations
- 2
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 3.76